Lattice Biologics Signs Definitive Agreement with Alumina Partners for $6 Million At-Will Offering Facility
Lattice Biologics Announces Planned Debt-to-Equity Conversion
Lattice Biologics Ltd. Transferred to TSX Venture Exchange Tier 2
Lattice Biologics Ltd. Reports Q1 2020 Results
Lattice Biologics Ltd. Reports Year End 2019 Results and Q1 Preliminary Q1 2020 Revenues
Spinal & Demineralized Bone Matrix (DBM) Allografts
Interesting news and advances in bioscience and technologies delivered to your inbox.
An emerging leader in the field of cellular therapies and tissue engineering
Lattice maintains headquarters, laboratory and manufacturing facilities in Belgrade, Montana as well as offices in Toronto Ontario.
© Copyright - Lattice Biologics Ltd. - All Rights Reserved